Steven Cohen's ENTX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 12,382 shares of Entera Bio Ltd. (ENTX) worth $13,744, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in ENTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 15,210 shares. Largest reduction occurred in Q3 2025, reducing 1.52 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Entera Bio (ENTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Entera Bio (ENTX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1.18 M | Reduce 98.96% | 12,382 | $1.11 |
| Q4 2025 | +15,210 | Add 1.29% | 1.19 M | $1.94 |
| Q3 2025 | -1.52 M | Reduce 56.31% | 1.18 M | $1.92 |
| Q1 2025 | +2.7 M | New Buy | 2.7 M | $1.70 |
Steven Cohen's Entera Bio Investment FAQs
Steven Cohen first purchased Entera Bio Ltd. (ENTX) in Q1 2025, acquiring 2,697,236 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Entera Bio Ltd. (ENTX) for 5 quarters since Q1 2025.
Steven Cohen's largest addition to Entera Bio Ltd. (ENTX) was in Q1 2025, adding 2,697,236 shares worth $4.59 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 12,382 shares of Entera Bio Ltd. (ENTX), valued at approximately $13,744.
As of the Q1 2026 filing, Entera Bio Ltd. (ENTX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Entera Bio Ltd. (ENTX) was 2,697,236 shares, as reported at the end of Q1 2025.